Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus.
about
The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infectionTwo highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytesCutaneous and mucosal human papillomaviruses differ in net surface charge, potential impact on tropismTetraspanin CD151 mediates papillomavirus type 16 endocytosisCurrent understanding of the mechanism of HPV infectionPapillomavirus Infectious Pathways: A Comparison of SystemsThe cytoskeleton in papillomavirus infectionConcepts of papillomavirus entry into host cellsHuman papillomavirus type 16 entry: retrograde cell surface transport along actin-rich protrusionsLarge scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomavirusesEntry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosisSubunit interactions in bovine papillomavirusStructural Basis of Oligosaccharide Receptor Recognition by Human PapillomavirusTarget cell cyclophilins facilitate human papillomavirus type 16 infectionDifferential dependence on host cell glycosaminoglycans for infection of epithelial cells by high-risk HPV typesClathrin- and caveolin-independent entry of human papillomavirus type 16--involvement of tetraspanin-enriched microdomains (TEMs)Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implicationsPotential anti-HPV and related cancer agents from marine resources: an overview.A central region in the minor capsid protein of papillomaviruses facilitates viral genome tethering and membrane penetration for mitotic nuclear entry.Mechanisms of cell entry by human papillomaviruses: an overview.The role of furin in papillomavirus infection.HPV16 infection of HaCaTs is dependent on β4 integrin, and α6 integrin processing.Differential binding patterns to host cells associated with particles of several human alphapapillomavirus types.The nuclear retention signal of HPV16 L2 protein is essential for incoming viral genome to transverse the trans-Golgi network.Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans.In vivo mechanisms of vaccine-induced protection against HPV infection.Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections.Binding and neutralization characteristics of a panel of monoclonal antibodies to human papillomavirus 58.The role of inflammation in HPV infection of the Oesophagus.Human papillomavirus species-specific interaction with the basement membrane-resident non-heparan sulfate receptor.The HPV16 and MusPV1 papillomaviruses initially interact with distinct host components on the basement membraneInteraction of human tumor viruses with host cell surface receptors and cell entryKallikrein-8 Proteolytically Processes Human Papillomaviruses in the Extracellular Space To Facilitate Entry into Host CellsOpposing effects of bacitracin on human papillomavirus type 16 infection: enhancement of binding and entry and inhibition of endosomal penetrationTopography of the Human Papillomavirus Minor Capsid Protein L2 during Vesicular Trafficking of Infectious Entry.Cyclophilins facilitate dissociation of the human papillomavirus type 16 capsid protein L1 from the L2/DNA complex following virus entry.Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implicationsThe U4 Antibody Epitope on Human Papillomavirus 16 Identified by Cryo-electron MicroscopyUse of an in vivo animal model for assessing the role of integrin α(6)β(4) and syndecan-1 in early steps in papillomavirus infection.Interaction of human papillomavirus type 16 particles with heparan sulfate and syndecan-1 molecules in the keratinocyte extracellular matrix plays an active role in infection.
P2860
Q21134079-6014DFE5-EABB-4643-9967-65F64C42B117Q21143868-B362834C-6C06-4BE5-9326-CABEA0748C82Q21245129-8275C3A3-8B40-42FD-8C2D-7B5AF4280CB1Q24307905-7E28B66D-2027-423C-A830-0EA29E4137A4Q24616134-C0F0E68D-1723-4D89-B3D6-18E49F838052Q26801497-E92E8A35-D551-4181-AFD8-3BF0439B58CDQ26861667-A13F60BC-212A-4DA6-9F86-6FE4172D3D12Q27026900-3112ADDC-CEC5-4825-9BF2-468B433CC645Q27318457-A85D9716-5DC9-4D58-9AC1-6BF3131A1A7EQ27325402-D40483CA-D360-4D9F-9D8A-EF3D02EF34A1Q27346336-EE2FA057-2120-4F4A-A11E-D5D8482375AEQ27660305-CF2A7164-2AD8-48B5-8A4B-80D900418AD0Q27666101-F9A92EDF-819A-406F-A732-33BD138F5016Q28475787-549E48FB-1056-450F-BC19-72536F76D94AQ28534531-92CACE3C-7570-476A-8F7D-B2ED58737463Q33374009-E93ED829-B067-4CB5-8837-7347FC2CB8FAQ33469751-97E1E283-E28D-48A6-8030-B1345FF8C09BQ33575647-7F7C50CA-302D-4C10-8C9B-B6C712066898Q33626382-CB3456A8-21DB-4645-B497-3EBA1DC2188BQ33663169-25881E56-9D14-42B2-89AB-BBD2F510101AQ33693739-C5633ACA-1127-46DA-9312-E7E94151DAE9Q33714325-C2CE3651-B803-44BD-9A41-781C89BA355AQ33923898-4936A074-5C9C-4A2B-BA81-5AA2E44EA125Q33970900-68C51896-B56D-4266-9167-3184E4829C0DQ34009523-0464DF22-EADB-437D-8E15-C6233FFCC6CBQ34125906-6A83527D-532D-4F6C-9B7F-9F606A587498Q34162277-9DC0D990-6030-4512-A4D2-23D8125516ACQ34641651-056429F8-6992-49A8-BF19-0C38A42FD089Q34660442-B4EBADD6-3F9D-4B96-89C2-AD9165E5E903Q34774775-CB060C56-DD75-4DE6-B2B1-D4CE432B0593Q35624920-B360D771-4C49-4B9D-94B1-4C6D65F1ED95Q35676027-E5FB2D88-F356-45D3-A68B-959C3581BBE6Q35758680-BA6F6ECA-2029-45C0-840F-F7BB53E1C491Q35868083-B355755D-C911-4B47-90E9-3E2AFB42520CQ36086288-E0D9C59A-FDB1-4C26-8CF4-22F6A62077C2Q36246390-E684C516-1241-4269-A341-76B3E949D018Q36253322-F3D06369-7AF7-48EE-ACE5-A7F0D52874B0Q36281141-3D33B3A5-2C1B-40A6-9D53-665A2564AA90Q36303591-3FAC5AFC-1DD9-4193-B7C9-AC5CAC72E8C1Q36376623-0125D720-DFDC-4121-873E-6CD9182824A0
P2860
Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Inhibition of transfer to seco ...... ptake of human papillomavirus.
@ast
Inhibition of transfer to seco ...... ptake of human papillomavirus.
@en
type
label
Inhibition of transfer to seco ...... ptake of human papillomavirus.
@ast
Inhibition of transfer to seco ...... ptake of human papillomavirus.
@en
prefLabel
Inhibition of transfer to seco ...... ptake of human papillomavirus.
@ast
Inhibition of transfer to seco ...... ptake of human papillomavirus.
@en
P2093
P2860
P356
P1433
P1476
Inhibition of transfer to seco ...... ptake of human papillomavirus.
@en
P2093
Hans-Christoph Selinka
Hetal D Patel
Kirsten Freitag
Luise Florin
Martin Sapp
Michaela Schmidtke
Vadim A Makarov
P2860
P304
10970-10980
P356
10.1128/JVI.00998-07
P407
P577
2007-08-08T00:00:00Z